Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model

Fil:Yovanovich, C. Universidad de Buenos Aires. Facultad de Ciencias Exactas y Naturales; Argentina.

Guardado en:

Detalles Bibliográficos
Autores principales:	Yovanovich, Carola Anabel Mariana, Paz, Dante Agustin
Publicado:	2008
Materias:	cyclooxygenase-2 inhibitor meloxicam Ovarian hyperstimulation syndrome VEGF arachidonic acid chorionic gonadotropin cyclooxygenase 1 cyclooxygenase 2 cyclooxygenase 2 inhibitor estradiol icosanoid prostaglandin rofecoxib seric gonadotropin vasculotropin vasculotropin receptor 1 vasculotropin receptor 2 animal experiment animal model animal tissue article controlled study drug mechanism female granulosa cell immunohistochemistry immunoreactivity nonhuman organ weight ovary follicle ovary hyperstimulation ovary weight priority journal protein expression rat stroma cell Wistar rat Animals Cyclooxygenase 2 Cyclooxygenase 2 Inhibitors Down-Regulation Female Gene Expression Humans Incidence Organ Size Ovarian Hyperstimulation Syndrome Ovary Rats Rats, Wistar Thiazines Thiazoles Vascular Endothelial Growth Factor A
Acceso en línea:	https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_00150282_v90_n4SUPPL_p1511_Quintana http://hdl.handle.net/20.500.12110/paper_00150282_v90_n4SUPPL_p1511_Quintana
Aporte de:	Biblioteca Digital - Facultad de Ciencias Exactas y Naturales (UBA) de Universidad de Buenos Aires

Ejemplares similares

Inhibition of cyclooxygenase-2 (COX-2) by meloxicam decreases the incidence of ovarian hyperstimulation syndrome in a rat model
por: Quintana, R., et al.

Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
por: Elia, Evelin Mariel, et al.
Publicado: (2013)

Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
por: Elia, E.M., et al.
Publicado: (2013)

Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
por: Elia, E.M., et al.

Metformin decreases the incidence of ovarian hyperstimulation syndrome: An experimental study
por: Elia, E.M., et al.
Publicado: (2013)

Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome
por: Abramovich, Dalhia Nurit, et al.
Publicado: (2014)

Local VEGF inhibition prevents ovarian alterations associated with ovarian hyperstimulation syndrome
por: Scotti, L., et al.

Obesity induced by cafeteria diet disrupts fertility in the rat by affecting multiple ovarian targets
por: Pustovrh, Maria Carolina, et al.
Publicado: (2015)

Obesity induced by cafeteria diet disrupts fertility in the rat by affecting multiple ovarian targets
por: Bazzano, M.V., et al.

Local administration of platelet-derived growth factor B (PDGFB) improves follicular development and ovarian angiogenesis in a rat model of Polycystic Ovary Syndrome
por: di Pietro, María Florencia, et al.
Publicado: (2016)

Local administration of platelet-derived growth factor B (PDGFB) improves follicular development and ovarian angiogenesis in a rat model of Polycystic Ovary Syndrome
por: Di Pietro, M., et al.

Spatiotemporal analysis of the protein expression of angiogenic factors and their related receptors during folliculogenesis in rats with and without hormonal treatment
por: Abramovich, Dalhia Nurit, et al.
Publicado: (2009)

Spatiotemporal analysis of the protein expression of angiogenic factors and their related receptors during folliculogenesis in rats with and without hormonal treatment
por: Abramovich, D., et al.

Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome
Publicado: (2012)

Angiopoietins/TIE2 system and VEGF are involved in ovarian function in a DHEA rat model of polycystic ovary syndrome
por: Abramovich, D., et al.

Cyclooxygenase-2 and prostaglandin F2α in syrian hamster leydig cells : Inhibitory role on luteinizing hormone/human chorionic gonadotropin-stimulated testosterone production
por: Frungieri, Mónica B., et al.
Publicado: (2006)

Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs
por: Parborell, M.Fernanda A., et al.
Publicado: (2008)

Regulation of ovarian angiogenesis and apoptosis by GnRH-I analogs
por: Parborell, F., et al.

Polycystic ovarian syndrome: temporal characterization of the induction and reversion process in an experimental model
por: Salvetti, Natalia Raquel, et al.
Publicado: (2004)

Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome
por: Irusta, Griselda, et al.
Publicado: (2011)

Administration of a gonadotropin-releasing hormone agonist affects corpus luteum vascular stability and development and induces luteal apoptosis in a rat model of ovarian hyperstimulation syndrome
por: Scotti, L., et al.

Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS)
Publicado: (2013)

Involvement of the ANGPTs/Tie-2 system in ovarian hyperstimulation syndrome (OHSS)
por: Scotti, L., et al.

Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model
por: di Pietro, María Florencia, et al.
Publicado: (2015)

Metformin regulates ovarian angiogenesis and follicular development in a female polycystic ovary syndrome rat model
por: Di Pietro, M., et al.

Cyclooxygenase-2 and prostaglandin F2α in syrian hamster leydig cells: inhibitory role on luteinizing hormone/human chorionic gonadotropin-stimulated testosterone production
Publicado: (2006)

Cyclooxygenase-2 and prostaglandin F2α in syrian hamster leydig cells: inhibitory role on luteinizing hormone/human chorionic gonadotropin-stimulated testosterone production
por: Frungieri, M.B., et al.

Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome
Publicado: (2016)

Sphingosine-1-phosphate restores endothelial barrier integrity in ovarian hyperstimulation syndrome
por: Scotti, L., et al.

Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis
Publicado: (2001)

Relationship of ovarian stimulation response with vascular endothelial growth factor and degree of granulosa cell apoptosis
por: Quintana, R., et al.

Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats
por: Abramovich, Dalhia Nurit, et al.
Publicado: (2011)

Altered expression of Bcl-2 and Bax in follicles within dehydroepiandrosterone-induced polycystic ovaries in rats
por: Bas, D., et al.

In vivo intrabursal administration of bioactive lipid sphingosine- 1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome
por: Irusta, Griselda, et al.
Publicado: (2017)

In vivo intrabursal administration of bioactive lipid sphingosine- 1-phosphate enhances vascular integrity in a rat model of ovarian hyperstimulation syndrome
por: Pietro, M.D., et al.

Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats
Publicado: (2006)

Effect of a vascular endothelial growth factor (VEGF) inhibitory treatment on the folliculogenesis and ovarian apoptosis in gonadotropin-treated prepubertal rats
por: Abramovich, D., et al.

Daily treatment with α-naphthoflavone enhances follicular growth and ovulation rate in the rat
por: Barreiro, Karina Andrea, et al.
Publicado: (2011)

Daily treatment with α-naphthoflavone enhances follicular growth and ovulation rate in the rat
por: Barreiro, K.A., et al.

Gonadotropin-releasing hormone antagonist antide inhibits apoptosis of preovulatory follicle cells in rat ovary
Publicado: (2005)